Incidence of Factor V Leiden and prothrombin G20210A in patients submitted to stem cell transplantation.

1. Richardson PG, Elias AD, Krishnan A, et al.Treatment of severe veno occlusive disease with defribotide: compassionate use results in efficacy without significant toxicity in high risk population. Blood 1997; 90(Suppl 1):252a. 2. Thung SN, Gerber MA, Bodenheimer HC Jr. Nodular regenerative hyperplasia of the liver in a patient with diabetes mellitus. Cancer 1982; 49:543-6. 3. Duvoux C, Kracht M, Lang P, Vernant JP, Zafrani ES, Dhumeaux D. Nodular regenerative hyperplasia of the liver associated with azathioprine therapy. Gastroenterol Clin Biol 1991; 15:968-73. 4. Ueno S, Tanabe G, Sueyoshi K, et al. Hepatic hemodynamics in a patient with nodular regenerative hyperplasia. Am J Gastroenterol 1996; 91:1012-5. 5. Connolly CE, O'Brien MJ. Nodular transformation of the liver: report of a case. Hum Pathol 1977; 8:3502. 6. Stromeyer FW, Ishak KG. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981; 12:60-71. 7. Cales P, Voigt JJ, Payen JL, et al. Diffuse vascular ectasia of the antrum, duodenum, and jejunum in a patient with nodular regenerative hyperplasia. Lack of response to portosystemic shunt or gastrectomy. Gut 1993; 34:558-61. 8. Snover DC, Weisdorf S, Bloomer J, McGlave P, Weisdorf D. Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989; 9:443-8. 9. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2.500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11:787-97.